148 related articles for article (PubMed ID: 17044774)
1. Mechanisms of curcumin- and EGF-receptor related protein (ERRP)-dependent growth inhibition of colon cancer cells.
Reddy S; Rishi AK; Xu H; Levi E; Sarkar FH; Majumdar AP
Nutr Cancer; 2006; 55(2):185-94. PubMed ID: 17044774
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptor (EGFR)-related protein inhibits multiple members of the EGFR family in colon and breast cancer cells.
Xu H; Yu Y; Marciniak D; Rishi AK; Sarkar FH; Kucuk O; Majumdar AP
Mol Cancer Ther; 2005 Mar; 4(3):435-42. PubMed ID: 15767552
[TBL] [Abstract][Full Text] [Related]
3. Curcumin enhances the effects of 5-fluorouracil and oxaliplatin in mediating growth inhibition of colon cancer cells by modulating EGFR and IGF-1R.
Patel BB; Sengupta R; Qazi S; Vachhani H; Yu Y; Rishi AK; Majumdar AP
Int J Cancer; 2008 Jan; 122(2):267-73. PubMed ID: 17918158
[TBL] [Abstract][Full Text] [Related]
4. Curcumin enhances dasatinib-induced inhibition of growth and transformation of colon cancer cells.
Nautiyal J; Banerjee S; Kanwar SS; Yu Y; Patel BB; Sarkar FH; Majumdar AP
Int J Cancer; 2011 Feb; 128(4):951-61. PubMed ID: 20473900
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor-related peptide inhibits growth of PC-3 prostate cancer cells.
Marciniak DJ; Rishi AK; Sarkar FH; Majumdar AP
Mol Cancer Ther; 2004 Dec; 3(12):1615-21. PubMed ID: 15634655
[TBL] [Abstract][Full Text] [Related]
6. Curcumin targets FOLFOX-surviving colon cancer cells via inhibition of EGFRs and IGF-1R.
Patel BB; Gupta D; Elliott AA; Sengupta V; Yu Y; Majumdar AP
Anticancer Res; 2010 Feb; 30(2):319-25. PubMed ID: 20332435
[TBL] [Abstract][Full Text] [Related]
7. Curcumin synergizes with resveratrol to inhibit colon cancer.
Majumdar AP; Banerjee S; Nautiyal J; Patel BB; Patel V; Du J; Yu Y; Elliott AA; Levi E; Sarkar FH
Nutr Cancer; 2009; 61(4):544-53. PubMed ID: 19838927
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor-related protein inhibits cell growth and induces apoptosis of BxPC3 pancreatic cancer cells.
Zhang Y; Banerjee S; Wang ZW; Marciniak DJ; Majumdar AP; Sarkar FH
Cancer Res; 2005 May; 65(9):3877-82. PubMed ID: 15867387
[TBL] [Abstract][Full Text] [Related]
9. Curcumin synergizes the growth inhibitory properties of Indian toad (Bufo melanostictus Schneider) skin-derived factor (BM-ANF1) in HCT-116 colon cancer cells.
Giri B; Gomes A; Sengupta R; Banerjee S; Nautiyal J; Sarkar FH; Majumdar AP
Anticancer Res; 2009 Jan; 29(1):395-401. PubMed ID: 19331178
[TBL] [Abstract][Full Text] [Related]
10. Regression of early and intermediate stages of colon cancer by targeting multiple members of the EGFR family with EGFR-related protein.
Schmelz EM; Xu H; Sengupta R; Du J; Banerjee S; Sarkar FH; Rishi AK; Majumdar AP
Cancer Res; 2007 Jun; 67(11):5389-96. PubMed ID: 17545620
[TBL] [Abstract][Full Text] [Related]
11. EGF receptor-related protein (ERRP) inhibits invasion of colon cancer cells and tubule formation by endothelial cells in vitro.
Rishi AK; Parikh R; Wali A; Durko L; Zhang L; Yu Y; Majumdar AP
Anticancer Res; 2006; 26(2A):1029-37. PubMed ID: 16619503
[TBL] [Abstract][Full Text] [Related]
12. EGF-receptor related protein causes cell cycle arrest and induces apoptosis of colon cancer cells in vitro and in vivo.
Levi E; Mohammad R; Kodali U; Marciniak D; Reddy S; Aboukameel A; Sarkar FH; Kucuk O; Rishi AK; Majumdar AP
Anticancer Res; 2004; 24(5A):2885-91. PubMed ID: 15517892
[TBL] [Abstract][Full Text] [Related]
13. (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells.
Shimizu M; Deguchi A; Lim JT; Moriwaki H; Kopelovich L; Weinstein IB
Clin Cancer Res; 2005 Apr; 11(7):2735-46. PubMed ID: 15814656
[TBL] [Abstract][Full Text] [Related]
14. Curcumin modulates the radiosensitivity of colorectal cancer cells by suppressing constitutive and inducible NF-kappaB activity.
Sandur SK; Deorukhkar A; Pandey MK; Pabón AM; Shentu S; Guha S; Aggarwal BB; Krishnan S
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):534-42. PubMed ID: 19735878
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity and Apoptosis Effects of Curcumin Analogue (2E,6E)-2,6-Bis(2,3-Dimethoxybenzylidine) Cyclohexanone (DMCH) on Human Colon Cancer Cells HT29 and SW620 In Vitro.
Rahim NFC; Hussin Y; Aziz MNM; Mohamad NE; Yeap SK; Masarudin MJ; Abdullah R; Akhtar MN; Alitheen NB
Molecules; 2021 Feb; 26(5):. PubMed ID: 33652694
[TBL] [Abstract][Full Text] [Related]
16. Regorafenib suppresses epidermal growth factor receptor signaling-modulated progression of colorectal cancer.
Liu YC; Tsai JJ; Weng YS; Hsu FT
Biomed Pharmacother; 2020 Aug; 128():110319. PubMed ID: 32502841
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of epidermal growth factor receptor-related protein is mediated by inactivation of ErbB receptors and nuclear factor-kappaB in pancreatic cancer.
Zhang Y; Banerjee S; Wang Z; Xu H; Zhang L; Mohammad R; Aboukameel A; Adsay NV; Che M; Abbruzzese JL; Majumdar AP; Sarkar FH
Cancer Res; 2006 Jan; 66(2):1025-32. PubMed ID: 16424038
[TBL] [Abstract][Full Text] [Related]
18. Akt is upstream and MAPKs are downstream of NF-κB in paclitaxel-induced survival signaling events, which are down-regulated by curcumin contributing to their synergism.
Bava SV; Sreekanth CN; Thulasidasan AK; Anto NP; Cheriyan VT; Puliyappadamba VT; Menon SG; Ravichandran SD; Anto RJ
Int J Biochem Cell Biol; 2011 Mar; 43(3):331-41. PubMed ID: 20883815
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex.
Plummer SM; Holloway KA; Manson MM; Munks RJ; Kaptein A; Farrow S; Howells L
Oncogene; 1999 Oct; 18(44):6013-20. PubMed ID: 10557090
[TBL] [Abstract][Full Text] [Related]
20. Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1.
Chen A; Xu J; Johnson AC
Oncogene; 2006 Jan; 25(2):278-87. PubMed ID: 16170359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
